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Breast reconstruction after mastectomy continues to evolve thanks in part to the development of unique technologies and enabling devices. The earliest reconstructions were described in the late 1800s,1 and the practice was revolutionized with introduction of breast implants in the 1960s and tissue expanders in the 1980s. 
More recently, the availability of acellular dermal matrix 
(ADM) grafts introduced in early 2000s and the modern 
cohesive gel breast implants (FDA approved in 2006–
2013) have permitted plastic surgeons to further enhance 
implant-based reconstruction and develop new protocols 
allowing for a shorter operative course and improved out-
comes.2 Today, the majority of patients and their surgeons 
choose an implant-based approach for breast reconstruc-
tion.3 The immediate direct-to-implant reconstruction 
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Background: The practice of breast reconstruction continues to evolve with the 
introduction of new technologies. The authors describe a unique approach allow-
ing immediate direct-to-implant reconstruction that can be performed on an out-
patient basis.
Methods: After a nipple-sparing mastectomy, acellular dermal matrix (ADM)-cov-
ered implants are placed in a prepectoral position in an immediate reconstruction. 
Assessment of results was performed via a retrospective review of demographic and 
procedural data.
Results: Forty-five patients (79 breasts), mean age 46.8 years, were treated with 
direct-to-implant reconstruction using ADM-wrapped implants placed above the 
muscle with mean follow-up of 23.1 months (median 22 mo). Mean body mass in-
dex was 24.3, and 15 patients (33.3%) were current or former smokers. Twenty-seven 
patients (60%) had prior breast surgery with 22 (49%) exposed to chemotherapy 
and 34 (76%) radiation. Procedure time averaged 155 minutes and hospital length 
of stay averaged 0.6 days. Complications included flap necrosis in 22 cases (28%), 
seroma in 12 (15%), infection in 8 (10%), rippling in 28 (35%), and contracture 
in 8 (10%). In 14 breasts (18%), postoperative wound complications (flap necrosis 
or infection) led to implant loss.
Conclusions: The availability of ADM and cohesive gel implants has allowed us 
to perform above-the-muscle implant breast reconstruction in reduced time and 
often on an outpatient basis. Complication rates were comparable to expect-
ed results of standard expander-to-implant, staged breast reconstruction. This 
technique is a viable option delivering clinically and aesthetically acceptable re-
sults in select patients. (Plast Reconstr Surg Glob Open 2016;4:e821; doi: 10.1097/
GOX.0000000000000839; Published online 22 July 2016.)
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has been shown to reduce operating room time, cost, and 
potential added morbidity associated with a 2-step 
expander/implant reconstruction.4–6 We have taken a 
logical next step and have developed a technique that 
combines ADM coverage and above-the-muscle implant 
placement in a single immediate-to-implant reconstruc-
tion, which we can now perform in an outpatient setting.
METHODS
This is a retrospective review of 45 patients, 79 breasts 
treated with immediate above-the-muscle implant recon-
struction performed by a single plastic surgeon between 
December 2011 and February 2015. Data describing base-
line patient demographics, comorbidities, operative char-
acteristics, and follow-up were collected from electronic 
health record reviews and patient interviews. Follow-up 
was obtained at least 7 months after the reconstruction or 
last-reported complication. We perform this procedure as 
standard of care for appropriate patients; thus, all patients 
provided standard surgical consent. Patient information 
was deidentified, complying with the Health Insurance 
Portability and Accountability Act.
SURGICAL	TECHNIQUE
Preoperative patient counseling includes review of the 
direct-to-implant reconstruction and other surgical options 
including, but not limited to, staged expander/implant 
and autologous tissue reconstructions and no reconstruc-
tion. Expected outcomes, risks, and potential for additional 
revision procedures are discussed and patients consented 
for the direct-to-implant procedure and their preferred al-
ternative options, should they become necessary.
Before surgery, the breast boundaries are marked to as-
sist the mastectomy surgeon and aid in implant size selec-
tion (Fig. 1). A general surgeon performs a nipple-sparing 
mastectomy using an inframammary or lateral approach 
with or without a supra- or infraareolar extension. The ap-
proach is carefully discussed with the surgeon to review 
experience and preference, oncologic requirements, and 
aesthetic needs of the patient. If necessary, a small mas-
topexy is performed through the supra-areolar extension 
for minor ptosis correction.
At completion of the mastectomy, the surgical team 
evaluates the mastectomy flaps for viability using their best 
clinical judgment and available techniques. In our facil-
ity, we have a SPY Elite System (Novadaq, Bonita Springs, 
Fla.) available to measure intraoperative tissue perfusion. 
During this evaluation, a 100% cursor is applied to an ob-
viously viable flap area and typically a relative reading of 
30 or above is considered to predict an adequate measure 
of tissue viability. If there is a predicted area of tissue ne-
crosis, it is debrided at this point. If this area is sizeable, we 
convert to an alternate approach.
Upon proceeding with the direct-to-implant route, 
the tissue is again evaluated with a sizer in place (Fig. 2). 
Appropriate pocket alterations are made to assist with a 
“hand in glove” implant fit. If necessary, a 2-0 PDS suture 
(Ethicon, Somerville, N.J.) is utilized to reinforce the in-
framammary fold or close the lateral pocket and axilla.
The approximate implant size is determined preop-
eratively, sometimes with the aid of 3D imaging. A Memo-
ryShape implant (Mentor, Santa Barbara, Ca.) is wrapped 
anteriorly and posteriorly with 16- × 20-cm-sized ADM 
[AlloDerm (LifeCell, Branchburg, N.J.) or FlexHD (MTF, 
Edison, N.J.)] (Fig. 3). In some cases, 2 pieces are used, 
forming a complete 360-degree implant wrap. The mar-
gins of the resultant unit are used to suture the implant 
to the chest wall and inframammary fold, avoiding migra-
tion or rotation of the implant. Alternatively, an anterior 
wrap using a single ADM piece can be used. This anterior 
wrap is secured with posterior spanning 2-0 PDS sutures, 
allowing the posterior texturing of the implant to assist in 
implant location and adhesiveness to avoid malposition. 
The implant/ADM is positioned in the pocket above the 
pectoralis and secured to the chest wall at 2 or more loca-
tions inferiorly. The posterior aspect of the nipple is po-
sitioned and sutured to the anterior portion of the ADM 
with 2-0 PDS suture to stabilize nipple location and avoid 
slippage. A 15Fr drain is placed in the mastectomy pocket, 
positioned around the periphery of the implant and fas-
tened at the skin level with 3-0 silk (Ethicon, Somerville, 
N.J.). The incision is closed with 3-0 monocryl (Ethicon, 
Somerville, N.J.) in the subcutaneous and subcuticular 
levels and the wound is sealed with tissue adhesive. The 
inframammary fold and lateral pocket are reinforced with 
Fig. 1. the breast boundaries are outlined with the patient sitting 
upright. For this technique, typically an inframammary or lateral 
breast incision is used.
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Mastisol and 1-in foam tape left in place for 24 hours. The 
patient is placed in a postoperative bra, reversed from 
anesthesia and sent to recovery. We use Exparel (Pacira, 
San Diego, Ca.) to further reduce postoperative discom-
fort, and typically narcotics are not required for pain. 
Patients may be kept overnight or sent home the same day. 
(See	 video,	 Supplemental	 Digital	 Content	 1, which 
displays a short video clip of the operative technique. This 
video is available in the “Related Videos” section of the 
Full-Text article on PRSGlobalOpen.com or available at 
http://links.lww.com/PRSGO/A239.)
Patients are seen within the first 3 postoperative days 
for wound and drain assessment. Drain removal usually 
occurs 10 days postoperatively or when drainage is below 
30 cc/d per drain for 2 consecutive days. Fat grafting or 
other revision procedures are sometimes desired to en-
hance aesthetic outcomes and can be performed subse-
quently. Figures 4 and 5 depict representative pre- and 
postoperative outcomes.
STATISTICAL	ANALYSIS
Descriptive statistics were generated for all demo-
graphic and surgical procedure-related and postopera-
tive outcome variables. For outcomes other than length 
of stay, the number of breast reconstructions was used for 
analysis. Both univariate and multivariable mixed-effects 
logistic regression models, adjusting for nesting effect of 
multiple breast reconstructions within the same patient, 
were performed to identify risk factors associated with 
each complication outcome (rippling, flap necrosis, infec-
tion, implant loss, and capsular contracture) separately. 
Because of the small sample size, only variables with a sig-
nificant P < 0.05 in the univariate analysis were entered in 
the multivariable regression models for further analysis. 
A 2-tailed P-value of less than 0.05 was considered signifi-
cant. All statistical analyses were performed using SAS 9.4 
statistical software (SAS Inc., Cary, N.C.).
RESULTS
A total of 45 women had 79 direct-to-implant reconstruc-
tions, which are included in this analysis. Thirty-four patients 
(75.6%) had bilateral reconstructions and the remaining 11 
(24.4%) had unilateral procedures. Patient characteristics 
are summarized in Table 1. Patients’ mean age was 46.8 ± 9.6 
years and mean body mass index (BMI) was 24.3 ± 5.4 kg/m2. 
Approximately 33% were either former or current smokers 
and 2% had diabetes mellitus. Sixty percent had previous 
breast surgery with 49% and 76% having prior chemothera-
py and radiation exposure, respectively.
Operative time averaged 155 minutes and patients 
spent less than a day on average in the hospital. Median 
Fig. 2. after the mastectomy, the pocket is sized and the skin flap 
viability is assessed. at this point, the decision to proceed with re-
construction using this technique or converting to an alternative 
approach is made.
Fig. 3. implant preparation: (a) Full 360-degree coverage—the aDM 
is wrapped around the implant circumference and sutured with run-
ning 2-0 PDS. edges are trimmed. B, anterior coverage with poste-
rior spanning sutures: this approach lowers the cost of the proce-
dure and exposes the posterior texture of the implant to assist with 
implant positioning.
Video Graphic 1. See video, Supplemental Digital Content 1, which 
displays a short video clip of the operative technique. this video is 
available in the “related Videos” section of the Full-text article on PrS-
globalOpen.com or available at http://links.lww.com/PRSGO/A239.)
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follow-up was 22 months after procedure. Postoperative 
complications, presented in Table 2, were most commonly 
rippling (35%) and flap necrosis (28%), seroma (15%), 
contracture (10%), and infection (10%). Infection was 
defined by the presence of cellulitis, purulent drainage, 
and/or elevated white blood cell count. Flap necrosis 
encompassed any area requiring debridement. Compli-
cations were managed conservatively in most cases; how-
ever, in 14 breast reconstructions (17.7%), postoperative 
implant loss was unavoidable: 11 due to tissue necrosis 
(13.9%) and 3 (3.8%) due to infection.
In the univariate logistic analysis adjusting for multi-
ple breast constructions nesting within the same patient, 
shown in Table 3, higher BMI (OR = 1.11, P = 0.037) 
and smoking (OR = 5.16, P = 0.012) were associated with 
higher risk of postoperative seroma. Patients who were 
smokers (OR = 6.35, P = 0.001) and had previous breast 
surgery (OR = 13.4, P = 0.004) and radiation (OR = 5.11, 
P = 0.077) were also more likely to have postoperative flap 
necrosis. Older patients (OR = 1.07, P = 0.033) and smokers 
(OR = 4.89, P = 0.010) were at greater risk of implant loss. 
Finally, smoking (OR = 1.13, P = 0.043) was also associated 
with higher risk of postoperative capsular contracture. In 
the multivariable analysis, smoking remained an indepen-
dent risk factor for seroma (OR = 4.07, P = 0.036), flap ne-
crosis (OR = 4.23, P = 0.031), and implant loss (OR = 5.36, 
0.009), whereas older age was also associated with higher 
risk of postoperative implant loss (OR = 1.06, P = 0.044).
DISCUSSION
In 2014, the ASPS reported over 100,000 breast recon-
structions in the United States with 83,000 incorporating 
an implant.3 Generally speaking, most plastic surgeons 
have concerns with placing the implant above the muscle 
because of thin mastectomy flaps and insufficient subcuta-
neous tissue remaining after a mastectomy. The potential 
risk of postoperative rippling, wound complications, im-
plant erosion and extrusion, infection, and capsular con-
tracture is felt to be higher than occurs with submuscular 
placement. Intuitively, the risk of complications increases 
with extended time in the OR; thus, minimizing the surgi-
Fig. 4. a 52-year-old patient with previous chemotherapy and radiation to right breast. Photographs (a, B, c) were taken before 
reconstruction. Photographs (D, e, F) at 6 months after bilateral nipple-sparing direct-to-implant reconstruction with cohesive gel 
implants in the prepectoral position.
Table 1. Patient Characteristics
Variables
Total	Patients	(N	=	45)
n %
Age (yr) 46.8 ± 9.6
BMI (kg/m2) 24.3 ± 5.4
Smoking
  Current smoking 6 13.3
  Former smoker 9 20.0
  Never smoking 30 66.7
Diabetes
  Yes 1 2.2
  No 44 97.8
Previous breast surgery
  Yes 27 60.0
  No 18 40.0
Chemotherapy
  Yes 22 48.9
  No 23 51.1
Radiation
  Yes 34 75.6
  No 11 24.4
Type of surgery
  Bilateral 34 75.6
  Unilateral 11 24.4
Expand size (cm) 757 ± 448
Fill volume (cc) 518 ± 127
Length of surgery (min) 155 ± 30
Length of stay (d) 0.62 ± 0.72
Length of follow-up (mo) 23.1 ± 10.4 (22)*
*Median follow-up.
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cal time for breast reconstruction is desirable. Using our 
technique, we eliminated a second surgery and reduced 
our complete mastectomy/reconstruction OR time to 155 
minutes, with the average patient hospital stay being 0.6 
days. Now, the majority of patients are released the same 
day without significant narcotics.
Any quality breast reconstruction begins with a quality 
mastectomy. A close working relationship with the treat-
ment team and a specific understanding by the mastectomy 
surgeon of the reconstructive plan and nuances are essen-
tial. Our patients are typically treated by 1 of 2 general sur-
geons who have become most familiar with this protocol, 
although over the course of this series 6 general surgeons 
performed the mastectomies. Variability among mastecto-
my surgeons may have played a role in our complications.
As adequate skin flaps with intact subcutaneous fat are 
critical for the success of the above-the-muscle technique, as-
sessment of the mastectomy before proceeding with recon-
struction is imperative. We believe real-time intraoperative 
tissue perfusion analysis is an extremely valuable tool. Our 
“Go/No Go” decision point is directly related to the amount 
of predicted nonviable tissue: if less than 10% of the flap 
has limited perfusion, it can likely be debrided, closed, and 
the direct-to-implant route maintained. Mastectomy flaps 
with 10% to 30% viability are more likely to need a tissue 
expander as opposed to an implant. Initially, we placed these 
expanders in the usual subpectoral plane with the ADM de-
fining the inferior pole. Currently, we position the expanders 
in the subcutaneous pocket without disruption of the pec-
toralis musculature. If greater than 30% of the mastectomy 
flap is predicted to have limited to no perfusion, the direct-
to-implant reconstruction should be abandoned in favor of 
alternative methods such as staged expander/implant or au-
tologous tissue reconstructions, or in some cases depending 
on clinical judgment and patient preference, no reconstruc-
tion. In the absence of a SPY system, we recommend plastic 
surgeons rely on their clinical judgment when appraising tis-
sue flap viability. Capillary refill, thickness of flaps, presence 
of subcutaneous tissue, and temperature to touch are several 
variables that may be evaluated when considering whether to 
proceed with direct-to-implant reconstruction.
Complications in this series were managed conser-
vatively in most cases with implant loss occurring in 14 
breasts. Unquestionably, comorbid conditions factor heav-
ily into the complications and success of any procedure, 
particularly those depending on flap perfusion and viabil-
ity. Smoking, diabetes mellitus, advanced age, and high 
BMI have all been shown to affect flap viability.7–9 In this 
series, we found a similar range of major complications 
that one would expect after a standard ADM/expander/
implant submuscular placement.10–15
Twenty-two breasts had some degree of flap necrosis, of 
which 11 (13.9%) can be categorized as major, resulting in 
implant loss. Certainly, some may have been related to our 
learning curve, particularly as early in the series we did not 
objectively measure tissue perfusion. Although we were not 
alarmed with our rate of implant loss, a review of the litera-
ture was performed to assess skin-sparing mastectomy (SSM) 
flap complications and implant loss rates, confirming our 
outcomes were similar to those seen by others.7,16–19 Garwood 
et al16 reported an overall 16.8% rate of implant loss in a 
series of 170 SSMs, with loss ranging from 31% in an early 
Table 2. Postoperative Complications
Complications
Total	Breast	Reconstructions	(N	=	79)
n %
Rippling 28 35.4
Seroma 12 15.2
Flap necrosis (all) 22 27.8
Infection (all)  8 10.1
Implant loss 14 17.7
  Due to necrosis 11 13.9
  Due to infection 3 3.8
Contracture 8 10.1
Table 3. Univariate Logistic Regression on Postoperative Complications by Breast Reconstruction (N = 79)
Risk	Factors
Rippling Seroma Flap	Necrosis
OR 95%	CI P OR 95%	CI P OR 95%	CI P
Age 0.95 0.90–1.01 0.086 1.03 0.96–1.10 0.384 1.04 0.98–1.09 0.211
BMI 0.90 0.80–1.01 0.079 1.11* 1.01–1.23 0.037 1.00 0.91–1.10 0.947
Smoking 1.13 0.29–2.09 0.859 5.16* 1.44–18.5 0.012 6.35* 2.18–18.4 0.001
Previous breast 
surgery
0.65 0.25–1.67 0.368 2.78 0.63–12.3 0.176 13.4* 2.30–23.9 0.004
Chemotherapy 1.00 0.40–2.50 0.993 1.45 0.43–4.86 0.552 0.48 0.18–1.30 0.145
Radiation 1.68 0.50–5.70 0.404 1.12 0.24–5.19 0.888 5.11 0.84–13.0 0.077
Risk	Factors Infection Implant	loss Contracture
OR 95%	CI P OR 95%	CI P OR 95%	CI P
Age 0.99 0.91–1.07 0.770 1.07* 1.01–1.15 0.033 0.99 0.91–1.07 0.737
BMI 1.02 0.90–1.16 0.736 1.06 0.96–1.17 0.274 1.05 0.93–1.17 0.429
Smoking 1.29 0.36–3.63 0.732 4.89* 1.47–11.2 0.010 1.13 1.02–1.70 0.043
Previous breast 
surgery
3.20 0.51–20.2 0.216 3.48 0.80–15.1 0.095 1.08 0.27–4.41 0.913
Chemotherapy 0.35 0.07–1.62 0.178 1.39 0.44–4.35 0.574 0.80 0.21–3.06 0.739
Radiation 4.96 0.25–18.6 0.294 2.71 0.44–16.9 0.286 0.76 0.16–3.68 0.729
*Only variables with a significant P < 0.05 in the univariate analysis were further entered in the multivariable analysis. For seroma, smoking remained a significant 
risk factor (OR = 4.07, 95% CI = 1.10–11.7, P = 0.036), but not BMI (OR = 1.08, 95% CI = 0.97–1.20, P = 0.145); for flap necrosis, smoking was a significant risk factor 
(OR = 4.23, 95% CI = 1.14–9.17, P = 0.031), but not previous breast surgery (OR = 1.78, 95% CI = 0.37–8.54, P = 0.469); for implant loss, both age (OR = 1.06, 95% 
CI = 1.01–1.15, P = 0.044) and smoking (OR = 5.36, 95% CI = 1.52–10.9, P = 0.009) remained significant risk factors in the multivariable analysis.
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cohort to 10% in a later group. Similarly, Hultman described 
flap loss in 24.3% of patients/17% of reconstructions after 
SSM with immediate reconstruction.7 Additionally, Chun 
et al17 reported an incidence of 11.8% major necrosis compli-
cations in nontumescent mastectomy patients. Comparable 
to our rate of 3.9% implant loss due to infection, Reish re-
ported an overall explant rate of 3.2% in 1952 immediate 
implant-based reconstructions, specifically assessing implant 
salvage in the presence of postoperative infection.18
Predictably, multivariate analysis demonstrated that 
smokers were more likely to have postoperative flap necro-
sis. Smoking and age remained significant risk factors in the 
multivariable analysis. This underscores the importance of 
patient selection and intraoperative assessment of tissue vi-
ability. Even with previous radiation therapy, however, this 
technique can be performed with acceptable outcomes.
Seroma occurred in 12 breasts (15%); however, only 5 
(6%) would be deemed clinically significant using the defi-
nition of requiring hospital stay, IV antibiotics, or device 
explant.14 One patient received IV antibiotics in the office, 
and the other 4 occurrences were associated with infection 
and flap necrosis, which combined necessitated explant. 
Other seromas were managed conservatively. As published 
reports suggest a potential increased seroma rate when 
ADMs are utilized, we typically leave drains in a bit lon-
ger, which may mitigate risk. When adjusting for multiple 
breast constructions within the same patient, higher BMI 
(OR = 1.11, P = 0.037) and smoking (OR = 5.56, P = 0.011) 
were associated with higher risk of postoperative seroma.
In our series with mean follow-up of close to 2 years, 
capsular contracture occurred in 8 breasts (5 patients) 
(10%), with the majority categorized as Baker II. This is 
well within the range anticipated with any breast recon-
struction. Smoking was the only variable associated with a 
significantly higher risk of postoperative capsular contrac-
ture (OR = 1.12, P = 0.048).
We must continuously analyze and refine our surgi-
cal technique. Traditionally, an implant or expander is 
placed in a complete submuscular or partial submuscular 
plane and the muscle used to improve upper pole cosme-
sis and decrease implant visibility. Ultimately, the muscle 
becomes thin and attenuated over time, limiting its advan-
tage. Additionally, disruption of the chest wall muscula-
ture not only significantly increases procedural discomfort 
but contributes to “hyperanimation” of the upper pole of 
the reconstruction, which can be unsightly.20
Initially, we used a “complete wrap” with two pieces of 
ADM placed around the anterior and posterior surfaces of 
the implant. With experience, we found that an anterior 
wrap using a single ADM piece was preferable. In addition 
to reducing cost, a free margin for positioning the implant 
is maintained and the textured posterior of the device is 
exposed to the chest wall to further secure its position pre-
serving the benefits associated with the ADM. About 50% 
of these cases were done with the “complete wrap” and the 
remaining utilized an anterior wrap.
In our Midwest-based practice, we select the implant 
best suited to each patient from a wide range of available 
shapes and sizes. Initially, cohesive gel implants were cho-
sen; however, we quickly progressed to using an ultraco-
hesive implant with enhanced texturing. These implants 
maintain their shape and in our experience are associated 
with decreased incidence of capsular contracture.
Patient-reported outcomes scores are not measured rou-
tinely, so quantitative analysis of patient satisfaction was not 
performed. Subjectively, we find patients to be quite satisfied 
Fig. 5. a 41-year-old patient who presented with recurrent cancer in right breast previously treated with lumpectomy. left column im-
ages (a, b, c) were taken before bilateral nipple-sparing mastectomy and direct-to-implant reconstruction. right column (d, e, f ) is after 
reconstruction with cohesive gel implants in the prepectoral position.
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with their aesthetic outcomes. As with other reconstructive 
methods, fat grafting is a helpful adjunct for perceived small 
aesthetic defects. In this series, as in all our reconstructions, 
fat grafting was used in 60% to 70% of patients to address 
any resultant rippling or upper pole implant visibility, par-
ticularly in very thin patients. This was usually done in the of-
fice under a local anesthetic and has become quite routine.
Broadly speaking, we do not believe that the major compli-
cations in this series are directly related to implant type or size 
or use of ADM, but more a function of overall patient health 
and comorbid conditions. That said, to maximize success, we 
recommend surgeons wishing to incorporate this technique 
into their practice begin their experience in nonsmokers with 
small–moderate sized breasts. As a guide, but not a strict cri-
terion, comorbidities are not hard contraindications to this 
approach, and although a higher BMI may in some cases in-
crease perioperative risk, it also allows for a thicker subcutane-
ous layer and better vascularized mastectomy flaps, which are 
critical for a successful outcome. Based on our learning curve 
and experience to date, perhaps the most ideal patients are 
those with Grade 1 or 2 ptosis and BMIs of 25 to 35 as they 
tend to have adequate subcutaneous fat.
This technique requires use of an ADM to provide sup-
plemental support to the remaining skin and subcutane-
ous tissue and minimize rippling and the risk of capsular 
contracture. There are a number of ADMs available, with 
the most clinical experience reported with human grafts. 
Recently, porcine ADM was used in a small series of direct-
to-implant nipple-sparing mastectomies using a prepectoral 
approach.21 In our series, two human ADMs were used to 
wrap the implants: AlloDerm (69%) and FlexHD Pliable 
(31%). Both ADMs performed well; however anecdotally, we 
observed differences in cosmetic results which we hypoth-
esize could be attributed to graft variability. We currently use 
a single type of ADM (FlexHD Pliable); however, we did not 
critically analyze FlexHD versus Alloderm, recognizing that 
a prospective comparative study to evaluate cosmetic out-
comes and soft tissue complications between different ADM 
materials is needed to confirm our observations.
CONCLUSIONS
The availability of an ADM combined with ultracohe-
sive-shaped breast implants allows us to perform an out-
patient above-the-muscle immediate breast reconstruction 
with an acceptable rate of major complications, excellent 
cosmetic results, and no hyperanimation deformity or pain 
associated with pectoral muscle disruption. This approach 
is a faster, less invasive option that should be considered in 
select cases. It offers patients a complete outpatient mas-
tectomy and reconstruction without compromising clini-
cal outcomes or further postoperative oncologic therapy. 
Additionally, the costs and complications associated with 
tissue expanders and a second surgery are eliminated.
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